Acceptance of COVID-19 Vaccination Among Health System Personnel
© Copyright 2021 by the American Board of Family Medicine..
INTRODUCTION: One-third of the general public will not accept Coronavirus disease 2019 (COVID-19) vaccination but factors influencing vaccine acceptance among health care personnel (HCP) are not known. We investigated barriers and facilitators to vaccine acceptance within 3 months of regulatory approval (primary outcome) among adult employees and students at a tertiary-care, academic medical center.
METHODS: We used a cross-sectional survey design with multivariable logistic regression. Covariates included age, gender, educational attainment, self-reported health status, concern about COVID-19, direct patient interaction, and prior influenza immunization.
RESULTS: Of 18,250 eligible persons, 3,347 participated. Two in 5 (40.5%) HCP intend to delay (n = 1020; 30.6%) or forgo (n = 331; 9.9%) vaccination. Male sex (adjusted OR [aOR], 2.43; 95% confidence interval [CI], 2.00-2.95; P < .001), prior influenza vaccination (aOR, 2.35; 95% CI, 1.75-3.18; P < .001), increased concern about COVID-19 (aOR, 2.40; 95% CI, 2.07-2.79; P < .001), and postgraduate education (aOR, 1.41; 95% CI, 1.21-1.65; P < .001) - but not age, direct patient interaction, or self-reported overall health - were associated with vaccine acceptance in multivariable analysis. Barriers to vaccination included concerns about long-term side effects (n = 1197, 57.1%), safety (n = 1152, 55.0%), efficacy (n = 777, 37.1%), risk-to-benefit ratio (n = 650, 31.0%), and cost (n = 255, 12.2%).Subgroup analysis of Black respondents indicates greater hesitancy to accept vaccination (only 24.8% within 3 months; aOR 0.13; 95% CI, 0.08-0.21; P < .001).
CONCLUSIONS: Many HCP intend to delay or refuse COVID-19 vaccination. Policymakers should impartially address concerns about safety, efficacy, side effects, risk-to-benefit ratio, and cost. Further research with minority subgroups is urgently needed.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:34 |
|---|---|
| Enthalten in: |
Journal of the American Board of Family Medicine : JABFM - 34(2021), 3 vom: 04. Mai, Seite 498-508 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Parente, Daniel J [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 12.07.2021 Date Revised 12.07.2021 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.3122/jabfm.2021.03.200541 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM326370552 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM326370552 | ||
| 003 | DE-627 | ||
| 005 | 20231225194439.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3122/jabfm.2021.03.200541 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1087.xml |
| 035 | |a (DE-627)NLM326370552 | ||
| 035 | |a (NLM)34088810 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Parente, Daniel J |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Acceptance of COVID-19 Vaccination Among Health System Personnel |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 12.07.2021 | ||
| 500 | |a Date Revised 12.07.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © Copyright 2021 by the American Board of Family Medicine. | ||
| 520 | |a INTRODUCTION: One-third of the general public will not accept Coronavirus disease 2019 (COVID-19) vaccination but factors influencing vaccine acceptance among health care personnel (HCP) are not known. We investigated barriers and facilitators to vaccine acceptance within 3 months of regulatory approval (primary outcome) among adult employees and students at a tertiary-care, academic medical center | ||
| 520 | |a METHODS: We used a cross-sectional survey design with multivariable logistic regression. Covariates included age, gender, educational attainment, self-reported health status, concern about COVID-19, direct patient interaction, and prior influenza immunization | ||
| 520 | |a RESULTS: Of 18,250 eligible persons, 3,347 participated. Two in 5 (40.5%) HCP intend to delay (n = 1020; 30.6%) or forgo (n = 331; 9.9%) vaccination. Male sex (adjusted OR [aOR], 2.43; 95% confidence interval [CI], 2.00-2.95; P < .001), prior influenza vaccination (aOR, 2.35; 95% CI, 1.75-3.18; P < .001), increased concern about COVID-19 (aOR, 2.40; 95% CI, 2.07-2.79; P < .001), and postgraduate education (aOR, 1.41; 95% CI, 1.21-1.65; P < .001) - but not age, direct patient interaction, or self-reported overall health - were associated with vaccine acceptance in multivariable analysis. Barriers to vaccination included concerns about long-term side effects (n = 1197, 57.1%), safety (n = 1152, 55.0%), efficacy (n = 777, 37.1%), risk-to-benefit ratio (n = 650, 31.0%), and cost (n = 255, 12.2%).Subgroup analysis of Black respondents indicates greater hesitancy to accept vaccination (only 24.8% within 3 months; aOR 0.13; 95% CI, 0.08-0.21; P < .001) | ||
| 520 | |a CONCLUSIONS: Many HCP intend to delay or refuse COVID-19 vaccination. Policymakers should impartially address concerns about safety, efficacy, side effects, risk-to-benefit ratio, and cost. Further research with minority subgroups is urgently needed | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Academic Medical Centers | |
| 650 | 4 | |a Acute Disease | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Chronic Disease | |
| 650 | 4 | |a Cross-Sectional Studies | |
| 650 | 4 | |a Health Personnel | |
| 650 | 4 | |a Linear Models | |
| 650 | 4 | |a Logistic Models | |
| 650 | 4 | |a Outpatients | |
| 650 | 4 | |a Pandemics | |
| 650 | 4 | |a Primary Health Care | |
| 650 | 4 | |a Quality of Life | |
| 650 | 4 | |a Self Report | |
| 650 | 4 | |a Surveys and Questionnaires | |
| 650 | 4 | |a Vaccination | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 700 | 1 | |a Ojo, Akinlolu |e verfasserin |4 aut | |
| 700 | 1 | |a Gurley, Tami |e verfasserin |4 aut | |
| 700 | 1 | |a LeMaster, Joseph W |e verfasserin |4 aut | |
| 700 | 1 | |a Meyer, Mark |e verfasserin |4 aut | |
| 700 | 1 | |a Wild, David M |e verfasserin |4 aut | |
| 700 | 1 | |a Mustafa, Reem A |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of the American Board of Family Medicine : JABFM |d 2006 |g 34(2021), 3 vom: 04. Mai, Seite 498-508 |w (DE-627)NLM160846994 |x 1558-7118 |7 nnns |
| 773 | 1 | 8 | |g volume:34 |g year:2021 |g number:3 |g day:04 |g month:05 |g pages:498-508 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3122/jabfm.2021.03.200541 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 34 |j 2021 |e 3 |b 04 |c 05 |h 498-508 | ||